Raynaud's phenomenon


Also found in: Medical, Wikipedia.

Ray·naud's phenomenon

 (rā-nōz′)
n.
Narrowing of the arteries and arterioles of the fingers and toes, often triggered by cold or stress, resulting in blanching, cyanosis, numbness, pain, and, in extreme cases, gangrene.

[After Maurice Raynaud (1834-1881), French physician.]
Translations

Raynaud's phenomenon

n. fenómeno de Raynaud, síntomas asociados con el síndrome de Raynaud.
Mentioned in ?
References in periodicals archive ?
Raynaud's phenomenon is a common but under-recognised condition.
In the same vein there is also Raynaud's Phenomenon, a restriction in blood vessels that could make someone feel cold, among other symptoms.
Pregnancy outcomes in females diagnosed with SLE before and after pregnancy were compared, and the associations with lupus nephritis, positive anti-Ro/SSA antibody, positive La/SSB antibody, C3 and C4, high blood pressure, positive aCL antibody, Raynaud's phenomenon, and lupus recurrence were evaluated.
To the Editor: A 65-year-old woman with calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) syndrome was admitted to hospital because of progressive dyspnea on exertion for about 1 year.
Purpose: The aim of the study was the assessment of the influence of MLS laser therapy on morphological changes in nailfold videocapillaroscopy (NVC), clinical features, and the serum NO level in patients with primary and secondary Raynaud's phenomenon (RP).
It could be: Raynaud's phenomenon, a condition where the blood vessels in your hands (or feet) constrict due to cold intolerance.
Calcinosis cutis of the fingertip associated with Raynaud's phenomenon.
Raynaud's phenomenon, first described in the mid-1800s by Maurice Raynaud, is a considered a vascular disease present in 3% to 5% of the general population.
In this case report, we have described a patient with chronic hepatitis B and D, who developed Raynaud's phenomenon, ischaemic digital necrosis and bilateral olecranon bursitis during Pegylated interferon therapy.
Raynaud's phenomenon is a common condition thought to affect up to 10 million people in the UK.
RAYNAUD'S phenomenon is thought to affect up to 10 million people in the UK.
Data from this preclinical study supported the company's recently enrolled STAR clinical trial, an FDAapproved, 88 patient, multi-center, randomized controlled Phase 3 trial of Cytori Cell Therapy for the treatment of hand dysfunction and Raynaud's Phenomenon in patients with scleroderma as well as the investigator-initiated, ADRESU urinary incontinence trial enrolling in Japan.